BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved ...

An oral dose of 100 mg progesterone in a bioidentical hormone therapy combination that includes estradiol is sufficient to counteract potential estrogenic stimulation of the endometrium while ...